NJ-based Champions Oncology develops oncology drugs and provides global clinical solutions.
NYC-based SELLAS Life Sciences develops late-stage oncology drugs, serving patients globally.
Anew Oncology, Inc.: An Arizona-based medical firm providing affordable, life-saving oncology drugs globally.
Nexo Therapeutics: Innovating small molecule oncology for effective cancer treatments.
Meliora Therapeutics: A biotech startup leveraging machine learning to decode oncology medications.
Intera Oncology, a specialist in colorectal and cholangiocarcinoma treatments, acquires and improves oncology drugs.
IDEAYA Biosciences, a California-based biotech firm, develops oncology-focused drugs for cancer treatment.
Akanocure: Focused on developing drugs for orphan and unmet oncology needs.
Bantam Pharmaceutical: Cost-efficient oncology drug discovery and development with experienced leadership.
NiKang Therapeutics: Pioneering in small molecule oncology drug discovery and development for cancer cure.
Vesselon develops targeted, encapsulated immuno-oncology complexes for effective, safe cancer treatment.
BioCurity: A clinical-stage biopharmaceutical firm innovating to enhance radiation therapy for cancer patients.
Illinois-based RiMO Therapeutics develops non-toxic oncology drugs, enhancing radiotherapy efficacy and reducing toxicity with its proprietary RiMO technology.
Incyte Corporation: An American biopharmaceutical firm specializing in oncology-focused small molecule drugs.
CBA Pharma, Inc.: A leading drug manufacturer specializing in medical oncology.
AmpliMed Corp: Pioneering small-molecule oncology drugs for effective cancer treatment since 1989.
Treadwell Therapeutics: A clinical-stage oncology firm developing innovative cancer treatments.
Esperance Pharmaceuticals: Developing targeted anticancer drugs, preserving normal cells in the US.
Oncology-focused Ascalon International develops drugs, conducts biomarker-based trials, and forms strategic alliances.